news
Biotech stock boom means more health innovation
The biotech sector's stock rally, which started in April 2025, is still going strong, hitting its stride and accelerating. This surge means more capital for companies pushing the boundaries of health and longevity, from new drugs to advanced diagnostics.
The biotech sector's stock rally, which started in April 2025, is still going strong, hitting its stride and accelerating. This surge means more capital for companies pushing the boundaries of health and longevity, from new drugs to advanced diagnostics.
The architecture take
More money flowing into biotech doesn't just mean bigger valuations; it translates to faster development cycles for things that can actually tweak your biology—think longevity interventions, novel therapies, and new ways to hack cellular function. Watch for what this unleashes.